Long-term daily use of 75 mg aspirin may reduce the long-term incidence of bowel cancer by a quarter, and deaths by a third, according to research published in The Lancet.
The longer the period that patients took the aspirin, the greater the reduction in colorectal cancer risk, the researchers found. The authors claimed that administering aspirin for five years or longer reduced risk of proximal colon cancer by around 70%.